Strengthening and rationalizing pharmacovigilance in the EU: Where is Europe heading to?: A review of the new EU legislation on pharmacovigilance

Drug Safety

Volumn 34, Issue 3, 2011, Pages 187-197

  Borg, John Joseph ^a   Aislaitner, George ^b   Pirozynski, Michal ^c   Mifsud, Stephen ^d  

^a Department of Medicines Authority ^*  (Malta)

^b National Organization for Medicines (EOF)   (Greece)

^c Postgraduate Medical School   (Poland)

^d European Union   (Belgium)

Author keywords

Legislation; Pharmacovigilance; Postmarketing surveillance.

Indexed keywords

ADVERSE DRUG REACTION; DECISION MAKING; DRUG INDUSTRY; DRUG LEGISLATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EUROPEAN UNION; HEALTH PRACTITIONER; HUMAN; INFORMATION PROCESSING; INFORMATION RETRIEVAL; METHODOLOGY; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANIMALS; DECISION MAKING; EUROPEAN UNION; HUMANS; LEGISLATION, DRUG; PHARMACEUTICAL PREPARATIONS; PRODUCT SURVEILLANCE, POSTMARKETING; PUBLIC HEALTH; RISK ASSESSMENT;

EID: 79951788370     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11586620-000000000-00000     Document Type: Review

References (11)

1. Commission of the European Communities. Proposal for a directive of the European Parliament and of the Council, amending, as regards pharmacovigilance, Directive 2001/83/EC on the community code relating to medicinal products for human use. COM(2008) 665 final [online]. Available from URL: http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri=COM:2008:0665:FIN:en:PDF [Accessed 2010 Apr 23]
2. Commission of the European Communities. Proposal for a regulation of the European Parliament and of the Council, amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. COM(2008) 664 final [online]. Available from URL: http://eur-lex.europa.eu/ LexUriServ/LexUriServ.do? uri=COM:2008:0664:FIN:en:PDF [Accessed 2010 Apr 23]
3. European Commission, Enterprise and Industry Directo- rate-General. Strategy to better protect public health by strengthening and rationalising EU pharmacovigilance: analysis of the results of the public consultation on legislative proposals [online]. Available from URL: http:// ec.europa.eu/ enterprise/sectors/pharmaceuticals/files/phar macovigilance/docs/information- april-2008/analysis-cons ultation-responses-200804-en.pdf [Accessed 2010 Apr 23]
4. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the community code relating to medicinal products for human use. 2001L0083-EN-3012.2008-006.001-1 [online]. Available from URL:http://ec.europa.eu/enterprise/sectors/pharmaceuticals/files/ eudralex/vol-1/dir-2001-83-cons/dir2001-83-cons-200812 30-en.pdf [Accessed 2010 Apr 23]
5. European Commission. Call for tender: an assessment of the European community system of pharmacovigilance: terms of reference [online]. Available from URL:http://ec.europa. eu/enterprise/sectors/pharmaceuticals/files/ pharmacos/docs/ doc2005/01-05/technical-specifications-en.pdf [Accessed 2010 Apr 23]
6. Buhrlen B, ReiX T, Beckmann C, et al. Assessment of the European community system of pharmacovigilance. Stuttgart: Fraunhofer IRB Verlag, 2006
7. European Commission. Citizen's summary: legal proposals on pharmacovigilance [online]. Available from URL: http://ec.europa.eu/enterprise/ sectors/pharmaceuticals/files/ pharmacos/pharmpack-12-2008/pharmacovigilance/en- su mmary-phvg-en.pdf [Accessed 2010 Apr 23]
8. Council of the European Union. Proposal for a Regulation of the European Parliament and of the Council amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency and proposal for a Directive of the European Parliament and of the Council amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use. 10779/10 [online]. Available from URL: http://register.consilium.europa.eu/pdf/en/10/ st10/st10779.en10.pdf [Accessed 2010 Sep 21]
9. The European Parliament and the Council of the European Union. Regulation (EU) No 1235/2010 of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, and Regulation (EC) No 1394/2007 on advanced therapy medicinal products [online]. Available from URL: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri= OJ:L:2010:348:0001:0016: EN:PDF [Accessed 2011 Jan 24]
10. The European Parliament and the Council of the European Union. Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use [online]. Available from URL: http://eur-lex.europa. eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:348:0074:0099: EN:PDF [Accessed 2011 Jan 24]
11. McAvan L. European Parliament, amendments 14-86 on the proposal for a regulation of the European Parliament and of the Council amending, as regards pharma-covigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. 2008/0257(COD) [online]. Available from URL: http://www.europarl.europa.eu/sides/ getDoc.do?pubRef=-//EP//NONSGML+COMPARL+PE -438.413+01+DOC+PDF+V0//EN&language=EN [Accessed 2010 Sep 21]